Literature DB >> 11579462

DNA polymerase eta undergoes alternative splicing, protects against UV sensitivity and apoptosis, and suppresses Mre11-dependent recombination.

M Thakur1, M Wernick, C Collins, C L Limoli, E Crowley, J E Cleaver.   

Abstract

Polymerase eta (pol eta) is a low-fidelity DNA polymerase that is the product of the gene, POLH, associated with the human XP variant disorder in which there is an extremely high level of solar-induced skin carcinogenesis. The complete human genomic sequence spans about 40 kb containing 10 coding exons and a cDNA of 2.14 kb; exon I is untranslated and is 6 kb upstream from the first coding exon. Using bacterial artificial chromosomes (BACs), the gene was mapped to human chromosome band 6p21 and mouse band 17D. The gene is expressed in most tissues, except for very low or undetectable levels in peripheral lymphocytes, fetal spleen, and adult muscle; exon II, however, is frequently spliced out in normal cells and in almost half the transcripts in the testis and fetal liver. Expression of POLH in a multicopy episomal vector proved nonviable, suggesting that overexpression is toxic. Expression from chromosomally integrated linear copies using either an EF1-alpha or CMV promoter was functional, resulting in cell lines with low or high levels of pol eta protein, respectively. Point mutations in the center of the gene and in a C-terminal cysteine and deletion of exon II resulted in inactivation, but addition of a terminal 3 amino acid C-terminal tag, or an N- or C-terminal green fluorescent protein, had no effect on function. A low level of expression of pol eta eliminated hMre11 recombination and partially restored UV survival, but did not prevent UV-induced apoptosis, which required higher levels of expression. Polymerase eta is therefore involved in S-phase checkpoint and signal transduction pathways that lead to arrest in S, apoptosis, and recombination. In normal cells, the predominant mechanism of replication of UV damage involves pol eta-dependent bypass, and Mre11-dependent recombination that acts is a secondary, backup mechanism when cells are severely depleted of pol eta. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11579462     DOI: 10.1002/gcc.1186

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  17 in total

1.  Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias.

Authors:  Zheng Xiao; Madhumita Ray; Chuancang Jiang; Alan B Clark; Igor B Rogozin; Marilyn Diaz
Journal:  Mol Immunol       Date:  2007-01-22       Impact factor: 4.407

Review 2.  Y-family DNA polymerases in mammalian cells.

Authors:  Caixia Guo; J Nicole Kosarek-Stancel; Tie-Shan Tang; Errol C Friedberg
Journal:  Cell Mol Life Sci       Date:  2009-04-15       Impact factor: 9.261

Review 3.  DNA polymerase eta and chemotherapeutic agents.

Authors:  Kai-ming Chou
Journal:  Antioxid Redox Signal       Date:  2011-03-18       Impact factor: 8.401

4.  Human DNA polymerase η has reverse transcriptase activity in cellular environments.

Authors:  Yan Su; Pratibha P Ghodke; Martin Egli; Lin Li; Yinsheng Wang; F Peter Guengerich
Journal:  J Biol Chem       Date:  2019-03-06       Impact factor: 5.157

5.  High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading.

Authors:  Robert E Goldsby; Laura E Hays; Xin Chen; Elise A Olmsted; William B Slayton; Gerry J Spangrude; Bradley D Preston
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

6.  The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function.

Authors:  Sikandar G Khan; Vanessa Muniz-Medina; Tala Shahlavi; Carl C Baker; Hiroki Inui; Takahiro Ueda; Steffen Emmert; Thomas D Schneider; Kenneth H Kraemer
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

7.  p53 suppression overwhelms DNA polymerase eta deficiency in determining the cellular UV DNA damage response.

Authors:  Rebecca R Laposa; Luzviminda Feeney; Eileen Crowley; Sebastien de Feraudy; James E Cleaver
Journal:  DNA Repair (Amst)       Date:  2007-09-05

8.  Translesion synthesis of 8,5'-cyclopurine-2'-deoxynucleosides by DNA polymerases η, ι, and ζ.

Authors:  Changjun You; Ashley L Swanson; Xiaoxia Dai; Bifeng Yuan; Jianshuang Wang; Yinsheng Wang
Journal:  J Biol Chem       Date:  2013-08-21       Impact factor: 5.157

9.  Xeroderma pigmentosum-variant patients from America, Europe, and Asia.

Authors:  Hiroki Inui; Kyu-Seon Oh; Carine Nadem; Takahiro Ueda; Sikandar G Khan; Ahmet Metin; Engin Gozukara; Steffen Emmert; Hanoch Slor; David B Busch; Carl C Baker; John J DiGiovanna; Deborah Tamura; Cornelia S Seitz; Alexei Gratchev; Wen Hao Wu; Kee Yang Chung; Hye Jin Chung; Esther Azizi; Roger Woodgate; Thomas D Schneider; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2008-03-27       Impact factor: 8.551

10.  Human DNA polymerase eta activity and translocation is regulated by phosphorylation.

Authors:  Yih-Wen Chen; James E Cleaver; Zafer Hatahet; Richard E Honkanen; Jang-Yang Chang; Yun Yen; Kai-Ming Chou
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.